Liquidia’s $53 Million Initial Public Offering


Cooley advised the underwriters on Liquidia Technologies’ $53.2 million initial public offering of 4,833,099 shares of common stock, which included 287,644 shares issued upon the underwriters’ partial exercise of their option to purchase additional shares to cover over-allotments.

Jefferies and Cowen acted as the lead book-running managers for the offering. Needham & Company and Wedbush PacGrow acted as co-managers for the offering.

Liquidia Technologies, which now trades on the Nasdaq Capital Market as “LQDA,” is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients.

Cooley advised with a team including

Involved fees earner: Brent Siler – Cooley LLP; Brian Leaf – Cooley LLP; Div Gupta – Cooley LLP; Madison Jones – Cooley LLP; Donald Shum – Cooley LLP; Jason Drory – Cooley LLP; Francis Wheeler – Cooley LLP; Natasha Leskovsek – Cooley LLP; Phil Mitchell – Cooley LLP; Robert Paster – Cooley LLP; Bill Christiansen – Cooley LLP; Aaron Nudelman – Cooley LLP; Jeffery Wyzykowski – Cooley LLP; Stephanie Gentile – Cooley LLP;

Law Firms: Cooley LLP;

Clients: Jefferies; Cowen and Company; Needham & Co.; Wedbush PacGrow;

Author: Ambrogio Visconti